NCT03815539

Brief Summary

2017 International Dry Eye Workshop (DEWS) defines dry eye as a multifactorial ocular surface disease characterized by tear film instability with disturbed visual function. As a smooth transparent structure and the outmost layer of the whole ocular refractive system, tear film plays an important role. In dry eye, the instability of tear film caused by a lack of tear volume or high evaporation makes it more vulnerable to break up during blinking intervals, exposing the rough epithelium of the corneal surface and introducing extra aberrations and scatter. This would affect image sharpness on the retina and lower the optical quality. Also, it had been observed that the dynamic tear film scattering was reduced and the objective optical quality was improved transiently after artificial tears instillation. Though these findings supported the fact of visual quality impairment in dry eye. It remains unclear how does the tear film instability affect the visual quality in specific. Whether it lowers the optical quality of the whole ocular or just affects the tear-film associated part alone and whether there is a correlation with the tear film function are still unknown and to be answered. So we wondered whether there is a correlation between the tear film function and the related optical quality in dry eye. Though it had been inspected that the invasive tear break up time by fluorescein staining was positively correlated with the related scattering of tear film. To the newest dry eye diagnosis criteria of 2017 DEWS, the non-invasive tear break-up time has been amended to the first line instead of the invasive methods, e.g. fluorescein staining, which was thought to be less accurate and less credible. What's more, the invasive method of tear film evaluation might introduce confounding factors to the successive optical quality assessment. So we need a more accurate investigation to the relationships of the tear film function and the optical quality in dry eye. This study was intended to measure the non-invasive tear break-up time and the objective optical quality in normal people and dry eye patients to illustrate this question. In addition, we will investigate the relation of evolution trends of NIKBUT and objective optical quality under artificial tears for a better illustration.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2016

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

January 15, 2018

Completed
1 year until next milestone

First Posted

Study publicly available on registry

January 24, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2019

Completed
Last Updated

January 24, 2019

Status Verified

January 1, 2018

Enrollment Period

3.5 years

First QC Date

January 15, 2018

Last Update Submit

January 23, 2019

Conditions

Keywords

dry eyenoninvasive tear breakup timetear film related optical qualitycorrelation analysis

Outcome Measures

Primary Outcomes (5)

  • The difference of tear film function as NIBUT by Keratograph 5M between dry eye and normal group

    Keratograph 5M was used for NIBUT to test in the dry eye and normal group for tear film function.

    One day visit

  • The difference of the optical quality as scattering index between dry eye and normal group

    The scattering index by OQAS for optical quality was tested in dry eye and normal group.

    One day visit

  • The correlation of NIBUT and scattering index in normal group

    Pearson correlation was tested between NIBUT and scattering index in normal group.

    One day visit

  • The correlation of NIBUT and scattering index in dry eye group

    Pearson correlation was tested between NIBUT and scattering index in dry eye group.

    One day visit

  • Time changing pattern of NIBUT and scattering index in dry eye group

    The NIBUT and the scattering index change was tested before and after 0.1% sodium hyaluronate instillation in dry eye group

    base line, 10, 30,60, 90, 120 min after 0.1% sodium hyaluronate instillation

Study Arms (1)

dry eye group

EXPERIMENTAL

Part of the subjects will be instilled with one drop of 0.1% sodium hyaluronate in one of their eyes, then they will be tested with the devices of Oculus Keratograph 5M and Optical Quality Analysis SystemⅡ at different time points (10min, 30min, 60min, 90min and 120min).

Device: 0.1% sodium hyaluronate

Interventions

In dry eye group, part of the subjects will be instilled with one drop of 0.1% sodium hyaluronate in one of their eyes, then they will be tested with the devices of Oculus Keratograph 5M and Optical Quality Analysis SystemⅡ at different time points (10min, 30min, 60min, 90min and 120min).

dry eye group

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • for dry eye group: Ocular Surface Disease Index (OSDI) between 13 to 32 and NIBUT \<10 seconds.
  • for normal group: in absence of ocular symptoms or signs.

You may not qualify if:

  • opacity of the refractive tissue
  • history of ocular surgery that might affect the tear film (eg, refractive surgery, punctum plug insertion, etc)
  • best corrected visual acuity of decimal vision \< 1.0
  • spherical error ≥ 6 diopters (D)
  • cylindrical error ≤-2.0 D or ≥+2.0D
  • allergy to the 0.1% sodium hyaluronate
  • any condition that might interfere with the optical quality.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center, Sun Yat-Sen University

Guangzhou, Guangdong, 510080, China

RECRUITING

MeSH Terms

Conditions

XerophthalmiaDry Eye Syndromes

Condition Hierarchy (Ancestors)

Conjunctival DiseasesEye DiseasesLacrimal Apparatus Diseases

Central Study Contacts

Henan Zhang, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 15, 2018

First Posted

January 24, 2019

Study Start

June 30, 2016

Primary Completion

December 28, 2019

Study Completion

December 28, 2019

Last Updated

January 24, 2019

Record last verified: 2018-01

Locations